Melanie Sharp Moderating Panel at 13th Summit on Biosimilars and Innovator Biologics

June 29, 2022

Young Conaway's Commercial Litigation Chair and Partner, Melanie Sharp, will be moderating a panel at the American Conference Institute's 13th Summit on Biosimilars and Innovator Biologics held in Boston on June 29, 2022.  The session entitled, "Advocating for Diversity in IP:  Practical Ideas for Implementing Change," will focus on strategies members of the pharmaceutical IP community can apply in order to realize the full benefits of a diverse workforce.  Ms. Sharp will be joined by esteemed panelists:

Jason Murata
Partner, Chair, Diversity, Equity & Inclusion Committee
Axinn, Veltrop & Harkrider LLP

Eldora L. Ellison, Ph.D.
Sterne, Kessler, Goldstein & Fox P.L.L.C.

K. Nicole Clouse
IP Counsel
Sarah Chapin Columbia
McDermott Will & Emery

Hannah Lee
Kramer Levin Naftalis & Frankel LLP

To learn more, visit the Summit's website